Early evidence of disease control was observed in the ongoing Phase 1 ACESOT-1051 trial, with three patients achieving stable disease in the 70 mg and 100 mg cohorts treated with the WEE1 inhibitor, A ...

Phase 1b/2a immune thrombocytopenia (ITP) trial FPI achieved, enrollment ongoing. Climb Bio is enrolling an open-label, dose-escalation Phase 1b/2a clinical trial of budoprutug in patients with ITP to ...

Q2 Revenue Growth of 2.5%, Currency Neutral Growth of 1.8% Q2 Annual Subscription Revenue Growth of 3.7%, Currency Neutral 3.0% Annual Subscription Revenue Rose to 53.5% of Total Revenue in Q2 ...

In a move to reach a wider target audience, the leading motorcycle player Royal Enfield has updated its hot-selling range, ...

Fine Organic Industries Ltd. reported consolidated revenue of Rs 5.88 billion, up 7% YoY but down 3% QoQ. Export markets ...

A series of critical motorways in the Mekong Delta are entering the home stretch, heralding a new era of regional ...

While Boyle bagged goals 100 and 101 for Hibs, courtesy of a smart finish at the back post and then a confident penalty that ...

Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company working to develop a new class of drugs based on targeted protein degradation, today reported financial results for the second ...

Presented preclinical data at the American Society of Clinical Oncology (ASCO) on CLD-401 demonstrating biological efficacy IL-15 supera ...

Presented preclinical data at the American Society of Clinical Oncology (ASCO) on CLD-401 demonstrating biological efficacy IL-15 superagonist delivery to metastatic tumor sites and reduced immune cle ...

On 22 July 2025, the UK Government announced a set of targeted reforms to the National Security and Investment Act 2021 (NSI ...

Sure, Target employees wear red shirts and khakis, but so do, well, lots of other people. That poor teen in a red shirt and ...